drugset / Trial / NCT04340700

Characterization of the Pharmacodynamic Response to Vaped THC

NCT04340700 ↗

Phase 3 Withdrawn Massachusetts General Hospital
RandomizedCrossoverTriple-blindBasic science

Summary

This study aims to characterize the pharmacodynamic response to vaped THC in young adult, occasional cannabis users with respect to outcomes such as stimulation and sedative effects, mood, anxiety, and craving, as well as cognitive and objective outcomes such as heart rate and cortisol changes with THC vs placebo.

Timeline

Start
2022-11-01
Primary completion
2025-10-01
Completion
2025-10-01

Outcome

Outcome not reported

Stopped (Business): “Funding not received”

Drugs

EvaluationDrugModalityDoseRoute
Subject THC Unknown 2 mg Inhaled

Indications

No indication recorded.